The Cooper Companies with ticker code (COO) have now 12 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 560 and 405 with a mean TP of 477.25. Given that the stocks previous close was at 405.07 this now indicates there is a potential upside of 17.8%. The 50 day moving average now sits at 419.15 and the 200 moving average now moves to 405.55. The company has a market cap of $19,863m. You can visit the company’s website by visiting: http://www.coopercos.com
The Cooper Companies operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services for enhancing health of women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians’ and gynecologists’ (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, eye care practitioners, and distributors. The Cooper Companies was founded in 1980 and is headquartered in San Ramon, California.
You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.